Mario Masellis, Ph.D. - Publications

Affiliations: 
Medical Science University of Toronto, Toronto, ON, Canada 
Area:
Cognitive Neurology

131 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mirza SS, Saeed U, Knight J, Ramirez J, Stuss DT, Keith J, Nestor SM, Yu D, Swardfager W, Rogaeva E, St George Hyslop P, Black SE, Masellis M. ɛ4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia. Neurology. PMID 31575706 DOI: 10.1212/WNL.0000000000008377  0.56
2019 Robertson AD, Udow SJ, Espay AJ, Merola A, Camicioli R, Lang AE, Masellis M. Orthostatic hypotension and dementia incidence: links and implications. Neuropsychiatric Disease and Treatment. 15: 2181-2194. PMID 31447560 DOI: 10.2147/NDT.S182123  0.32
2019 Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K, Tierney MC, Andrew M, Hsiung GR, Camicioli R, Smith EE, et al. The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-13. PMID 31309917 DOI: 10.1017/cjn.2019.27  0.56
2019 Dilliott AA, Farhan SM, Ghani M, Sato C, Zhang M, McIntyre AD, Cao H, Racacho L, Robinson JF, Strong MJ, Masellis M, Bulman DE, Rogaeva E, Black SE, Finger E, et al. Genetic variation in the Ontario Neurodegenerative Disease Research Initiative. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-24. PMID 31217043 DOI: 10.1017/cjn.2019.228  0.56
2019 Valli M, Cho SS, Masellis M, Chen R, Rusjan P, Kim J, Koshimori Y, Mihaescu A, Strafella AP. DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum. Molecular Neurobiology. PMID 30847741 DOI: 10.1007/s12035-019-1543-0  0.32
2019 Mutsaerts HJMM, Mirza SS, Petr J, Thomas DL, Cash DM, Bocchetta M, de Vita E, Metcalfe AWS, Shirzadi Z, Robertson AD, Tartaglia MC, Mitchell SB, Black SE, Freedman M, Tang-Wai D, ... ... Masellis M, et al. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study. Brain : a Journal of Neurology. PMID 30847466 DOI: 10.1093/brain/awz039  0.56
2019 Shirzadi Z, Stefanovic B, Mutsaerts HJMM, Masellis M, MacIntosh BJ. Classifying cognitive impairment based on the spatial heterogeneity of cerebral blood flow images. Journal of Magnetic Resonance Imaging : Jmri. PMID 30666734 DOI: 10.1002/jmri.26650  0.44
2018 Yu D, Hennebelle M, Sahlas DJ, Ramirez J, Gao F, Masellis M, Cogo-Moreira H, Swartz RH, Herrmann N, Chan PC, Pettersen JA, Stuss DT, Black SE, Taha AY, Swardfager W. Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment. Translational Stroke Research. PMID 30443886 DOI: 10.1007/s12975-018-0672-5  0.56
2018 Udow SJ, Hobson DE, Kleiner G, Masellis M, Fox SH, Lang AE, Marras C. Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease. Movement Disorders Clinical Practice. 5: 66-74. PMID 30363445 DOI: 10.1002/mdc3.12563  0.32
2018 Desmarais P, Rohrer JD, Nguyen QD, Herrmann N, Stuss DT, Lang AE, Boxer AL, Dickerson BC, Rosen H, van Swieten JC, Meeter LH, Borroni B, Tartaglia MC, Feldman HH, Black SE, ... Masellis M, et al. Therapeutic trial design for frontotemporal dementia and related disorders. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30361298 DOI: 10.1136/jnnp-2018-318603  0.56
2018 Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, ... ... Masellis M, et al. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia. Annals of Neurology. PMID 30255971 DOI: 10.1002/ana.25333  0.56
2018 Sapkota S, Ramirez J, Stuss DT, Masellis M, Black SE. Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women. Alzheimer's Research & Therapy. 10: 89. PMID 30185213 DOI: 10.1186/s13195-018-0419-2  0.56
2018 Lim ASP, Gaiteri C, Yu L, Sohail S, Swardfager W, Tasaki S, Schneider JA, Paquet C, Stuss DT, Masellis M, Black SE, Hugon J, Buchman AS, Barnes LL, Bennett DA, et al. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. Plos Medicine. 15: e1002647. PMID 30180184 DOI: 10.1371/journal.pmed.1002647  0.56
2018 Shirzadi Z, Robertson AD, Metcalfe AW, Duff-Canning S, Marras C, Lang AE, Masellis M, MacIntosh BJ. Brain tissue pulsatility is related to clinical features of Parkinson's disease. Neuroimage. Clinical. 20: 222-227. PMID 30090696 DOI: 10.1016/j.nicl.2018.07.017  0.44
2018 Lipsman N, Meng Y, Bethune AJ, Huang Y, Lam B, Masellis M, Herrmann N, Heyn C, Aubert I, Boutet A, Smith GS, Hynynen K, Black SE. Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound. Nature Communications. 9: 2336. PMID 30046032 DOI: 10.1038/s41467-018-04529-6  0.56
2018 Mihaescu AS, Masellis M, Graff-Guerrero A, Kim J, Criaud M, Cho SS, Ghadery C, Valli M, Strafella AP. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis. Brain Imaging and Behavior. PMID 29971686 DOI: 10.1007/s11682-018-9922-0  0.32
2018 Rapoport MJ, Zucchero Sarracini C, Kiss A, Lee L, Byszewski A, Seitz DP, Vrkljan B, Molnar F, Herrmann N, Tang-Wai DF, Frank C, Henry B, Pimlott N, Masellis M, Naglie G. Computer-Based Driving in Dementia Decision Tool With Mail Support: Cluster Randomized Controlled Trial. Journal of Medical Internet Research. 20: e194. PMID 29802093 DOI: 10.2196/jmir.9126  0.56
2018 Saeed U, Mirza SS, MacIntosh BJ, Herrmann N, Keith J, Ramirez J, Nestor SM, Yu Q, Knight J, Swardfager W, Potkin SG, Rogaeva E, George-Hyslop PS, Black SE, Masellis M. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29782824 DOI: 10.1016/j.jalz.2018.04.005  0.56
2018 Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, et al. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology. PMID 29752303 DOI: 10.1212/WNL.0000000000005660  0.32
2018 Pottier C, Zhou X, Perkerson RB, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, ... ... Masellis M, et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. The Lancet. Neurology. PMID 29724592 DOI: 10.1016/S1474-4422(18)30126-1  0.56
2018 Dilliott AA, Farhan SMK, Ghani M, Sato C, Liang E, Zhang M, McIntyre AD, Cao H, Racacho L, Robinson JF, Strong MJ, Masellis M, Bulman DE, Rogaeva E, Lang A, et al. Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease. Journal of Visualized Experiments : Jove. PMID 29683450 DOI: 10.3791/57266  0.56
2018 Desmarais P, Miville C, Milán-Tomás Á, Nguyen QD, Ojeda-López C, Masellis M, Black SE, Andrade DM, Herrmann N. Age representation in antiepileptic drug trials: A systematic review and meta-analysis. Epilepsy Research. 142: 9-15. PMID 29544171 DOI: 10.1016/j.eplepsyres.2018.03.005  0.56
2018 Schneider R, McKeever P, Kim T, Graff C, van Swieten JC, Karydas A, Boxer A, Rosen H, Miller BL, Laforce R, Galimberti D, Masellis M, Borroni B, Zhang Z, Zinman L, et al. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29434051 DOI: 10.1136/jnnp-2017-317492  0.52
2018 Swardfager W, Cogo-Moreira H, Masellis M, Ramirez J, Herrmann N, Edwards JD, Saleem M, Chan P, Yu D, Nestor SM, Scott CJM, Holmes MF, Sahlas DJ, Kiss A, Oh PI, et al. The effect of white matter hyperintensities on verbal memory: Mediation by temporal lobe atrophy. Neurology. PMID 29374101 DOI: 10.1212/WNL.0000000000004983  0.56
2017 Saeed U, Masellis M. Unraveling PINK1 regulation: Ubiquitination of its mature form and insights for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28976028 DOI: 10.1002/mds.27171  0.32
2017 Espay AJ, Da Prat GA, Dwivedi AK, Rodriguez-Porcel F, Vaughan JE, Rosso M, Devoto JL, Duker AP, Masellis M, Smith CD, Mandybur JGT, Merola A, Lang AE. Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration. Annals of Neurology. PMID 28892572 DOI: 10.1002/ana.25046  0.32
2017 Swardfager W, Yu D, Scola G, Cogo-Moreira H, Chan P, Zou Y, Herrmann N, Lanctôt KL, Ramirez J, Gao F, Masellis M, Swartz RH, Sahlas DJ, Chan PC, Ojeda-Lopez C, et al. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease. Neurobiology of Aging. PMID 28756941 DOI: 10.1016/j.neurobiolaging.2017.06.029  0.56
2017 Desmarais P, Lanctôt KL, Masellis M, Black SE, Herrmann N. Social inappropriateness in neurodegenerative disorders. International Psychogeriatrics. 1-11. PMID 28689508 DOI: 10.1017/S1041610217001260  0.56
2017 Shirzadi Z, Stefanovic B, Chappell MA, Ramirez J, Schwindt G, Masellis M, Black SE, MacIntosh BJ. Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI. Journal of Magnetic Resonance Imaging : Jmri. PMID 28681479 DOI: 10.1002/jmri.25807  0.56
2017 Montero-Odasso M, Pieruccini-Faria F, Bartha R, Black SE, Finger E, Freedman M, Greenberg B, Grimes DA, Hegele RA, Hudson C, Kleinstiver PW, Lang AE, Masellis M, McLaughlin PM, Munoz DP, et al. Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI). Journal of Alzheimer's Disease : Jad. PMID 28671116 DOI: 10.3233/JAD-170149  0.56
2017 Mutsaerts HJMM, Petr J, Thomas DL, Vita E, Cash DM, Osch MJPV, Golay X, Groot PFC, Ourselin S, Swieten JV, Laforce R, Tagliavini F, Borroni B, Galimberti D, Rowe JB, ... ... Masellis M, et al. Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI). Journal of Magnetic Resonance Imaging : Jmri. PMID 28480617 DOI: 10.1002/jmri.25751  0.44
2017 Keith J, Gao FQ, Noor R, Kiss A, Balasubramaniam G, Au K, Rogaeva E, Masellis M, Black SE. Collagenosis of the Deep Medullary Veins: An Underrecognized Pathologic Correlate of White Matter Hyperintensities and Periventricular Infarction? Journal of Neuropathology and Experimental Neurology. 76: 299-312. PMID 28431180 DOI: 10.1093/jnen/nlx009  0.56
2017 Lin VY, Chung J, Callahan BL, Smith L, Gritters N, Chen JM, Black SE, Masellis M. Development of cognitive screening test for the severely hearing impaired: Hearing-impaired MoCA. The Laryngoscope. 127: S4-S11. PMID 28409842 DOI: 10.1002/lary.26590  0.56
2017 Butcher NJ, Marras C, Pondal M, Rusjan P, Boot E, Christopher L, Repetto GM, Fritsch R, Chow EW, Masellis M, Strafella AP, Lang AE, Bassett AS. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease. Brain : a Journal of Neurology. PMID 28369257 DOI: 10.1093/brain/awx053  0.32
2017 Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, Masellis M. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Translational Neurodegeneration. 6: 8. PMID 28360997 DOI: 10.1186/s40035-017-0076-6  0.56
2017 Cameron DH, Zucchero Sarracini C, Rozmovits L, Naglie G, Herrmann N, Molnar F, Jordan J, Byszewski A, Tang-Wai D, Dow J, Frank C, Henry B, Pimlott N, Seitz D, Vrkljan B, ... ... Masellis M, et al. Development of a decision-making tool for reporting drivers with mild dementia and mild cognitive impairment to transportation administrators. International Psychogeriatrics. 1-13. PMID 28325164 DOI: 10.1017/S1041610217000242  0.56
2017 Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, et al. Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28150432 DOI: 10.1002/mds.26907  0.32
2017 Nestor SM, Mišić B, Ramirez J, Zhao J, Graham SJ, Verhoeff NP, Stuss DT, Masellis M, Black SE. Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28137552 DOI: 10.1016/j.jalz.2016.12.007  0.56
2017 Mutsaerts HJ, Petr J, Václavů L, van Dalen JW, Robertson AD, Caan MW, Masellis M, Nederveen AJ, Richard E, MacIntosh BJ. The spatial coefficient of variation in arterial spin labeling cerebral blood flow images. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X16683690. PMID 28058975 DOI: 10.1177/0271678X16683690  0.44
2016 Farhan SM, Bartha R, Black SE, Corbett D, Finger E, Freedman M, Greenberg B, Grimes DA, Hegele RA, Hudson C, Kleinstiver PW, Lang AE, Masellis M, McIlroy WE, McLaughlin PM, et al. The Ontario Neurodegenerative Disease Research Initiative (ONDRI). The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-7. PMID 28003035 DOI: 10.1017/cjn.2016.415  0.56
2016 Graham NL, Leonard C, Tang-Wai DF, Black S, Chow TW, Scott CJ, McNeely AA, Masellis M, Rochon E. Lack of Frank Agrammatism in the Nonfluent Agrammatic Variant of Primary Progressive Aphasia. Dementia and Geriatric Cognitive Disorders Extra. 6: 407-423. PMID 27790240 DOI: 10.1159/000448944  0.48
2016 Lam B, Khan A, Keith J, Rogaeva E, Bilbao J, St George-Hyslop P, Ghani M, Freedman M, Stuss DT, Chow T, Black SE, Masellis M. Characterizing familial corticobasal syndrome due to Alzheimer's pathology and PSEN1 mutations. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27743520 DOI: 10.1016/j.jalz.2016.08.014  0.56
2016 Udow SJ, Robertson AD, MacIntosh BJ, Espay AJ, Rowe JB, Lang AE, Masellis M. 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27613160 DOI: 10.1136/jnnp-2016-314123  0.44
2016 Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE. Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets. The Lancet. Neurology. 15: 954-66. PMID 27478953 DOI: 10.1016/S1474-4422(16)30079-5  0.32
2016 Masellis M, Collinson S, Freeman N, Tampakeras M, Levy J, Tchelet A, Eyal E, Berkovich E, Eliaz RE, Abler V, Grossman I, Fitzer-Attas C, Tiwari A, Hayden MR, Kennedy JL, et al. Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study. Brain : a Journal of Neurology. PMID 27190009 DOI: 10.1093/brain/aww109  0.52
2016 Gasca-Salas C, Masellis M, Khoo E, Shah BB, Fisman D, Lang AE, Kleiner-Fisman G. Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis. Plos One. 11: e0153852. PMID 27100392 DOI: 10.1371/journal.pone.0153852  0.32
2015 Robertson AD, Messner MA, Shirzadi Z, Kleiner-Fisman G, Lee J, Hopyan J, Lang AE, Black SE, MacIntosh BJ, Masellis M. Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders. Parkinsonism & Related Disorders. PMID 26639982 DOI: 10.1016/j.parkreldis.2015.11.019  0.36
2015 Janik R, Thomason LA, Chaudhary S, Dorr A, Scouten A, Schwindt G, Masellis M, Stanisz GJ, Black SE, Stefanovic B. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition. Biochimica Et Biophysica Acta. PMID 26521151 DOI: 10.1016/j.bbadis.2015.10.023  0.36
2015 Makedonov I, Chen JJ, Masellis M, MacIntosh BJ. Physiological fluctuations in white matter are increased in Alzheimer's disease and correlate with neuroimaging and cognitive biomarkers. Neurobiology of Aging. PMID 26476600 DOI: 10.1016/j.neurobiolaging.2015.09.010  0.36
2015 Ludmer JA, Levitan R, Gonzalez A, Kennedy J, Villani V, Masellis M, Basile VS, Atkinson L. DRD2 and SLC6A3 moderate impact of maternal depressive symptoms on infant cortisol. Psychoneuroendocrinology. 62: 243-251. PMID 26342565 DOI: 10.1016/j.psyneuen.2015.08.026  0.52
2015 Ramirez J, McNeely AA, Scott CJ, Masellis M, Black SE. White matter hyperintensity burden in elderly cohort studies. The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26208292 DOI: 10.1016/j.jalz.2015.06.1886  0.52
2015 Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, De Vita E, Masellis M, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. The Lancet. Neurology. 14: 253-62. PMID 25662776 DOI: 10.1016/S1474-4422(14)70324-2  0.52
2015 Stamenova V, Roy EA, Szilagyi G, Honjo K, Black SE, Masellis M. Progression of limb apraxia in corticobasal syndrome: neuropychological and functional neuroimaging report of a case series. Neurocase. 21: 642-59. PMID 25325827 DOI: 10.1080/13554794.2014.964730  0.52
2015 Khoury JE, Gonzalez A, Levitan RD, Pruessner JC, Chopra K, Basile VS, Masellis M, Goodwill A, Atkinson L. Summary cortisol reactivity indicators: Interrelations and meaning Neurobiology of Stress. 2: 34-43. DOI: 10.1016/j.ynstr.2015.04.002  0.52
2015 Khoury JE, Gonzalez A, Levitan R, Masellis M, Basile V, Atkinson L. Infant Emotion Regulation Strategy Moderates Relations between Self-Reported Maternal Depressive Symptoms and Infant HPA Activity Infant and Child Development. DOI: 10.1002/icd.1916  0.52
2014 Misch MR, Mitchell S, Francis PL, Sherborn K, Meradje K, McNeely AA, Honjo K, Zhao J, Scott CJ, Caldwell CB, Ehrlich L, Shammi P, MacIntosh BJ, Bilbao JM, Lang AE, ... ... Masellis M, et al. Differentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomography. Alzheimer's Research & Therapy. 6: 71. PMID 25484929 DOI: 10.1186/s13195-014-0071-4  0.52
2014 Rapoport MJ, Herrmann N, Haider S, Sarracini CZ, Molnar F, Frank C, Masellis M, Tang-Wai D, Kiss A, Pimlott N, Naglie G. Physician sex is a predictor of reporting drivers with mild cognitive impairment and mild dementia to transportation authorities. Journal of the American Geriatrics Society. 62: 201-3. PMID 25180390 DOI: 10.1111/jgs.12627  0.52
2014 Rapoport MJ, Naglie G, Herrmann N, Zucchero Sarracini C, Mulsant BH, Frank C, Kiss A, Seitz D, Vrkljan B, Masellis M, Tang-Wai D, Pimlott N, Molnar F. Developing physician consensus on the reporting of patients with mild cognitive impairment and mild dementia to transportation authorities in a region with mandatory reporting legislation. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 1530-43. PMID 24406250 DOI: 10.1016/j.jagp.2013.12.002  0.52
2013 Konvalinka A, Srivastava S, Masellis M. Taking the Kidney Personally: The Quest for Novel Antigens of Idiopathic Membranous Nephropathy through Proteomic Approaches - Per Ardua Ad Astra? Current Pharmacogenomics and Personalized Medicine. 11: 5-7. PMID 24795785 DOI: 10.2174/1875692111311010002  0.52
2013 Rosa-Neto P, Hsiung GY, Masellis M. Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians. Alzheimer's Research & Therapy. 5: S8. PMID 24565514 DOI: 10.1186/alzrt223  0.52
2013 Masellis M, Sherborn K, Neto P, Sadovnick DA, Hsiung GY, Black SE, Prasad S, Williams M, Gauthier S. Early-onset dementias: diagnostic and etiological considerations. Alzheimer's Research & Therapy. 5: S7. PMID 24565469 DOI: 10.1186/alzrt197  0.52
2013 Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, Black SE. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing. Journal of the American Geriatrics Society. 61: 2181-5. PMID 24320735 DOI: 10.1111/jgs.12541  0.52
2013 Kalia LV, Lang AE, Aviv RI, Masellis M. Author response. Neurology. 81: 1181. PMID 24191352 DOI: 10.1212/WNL.0b013e3182a7a945  0.52
2013 Civardi C, Collini A, Kalia LV, Lang AE, Aviv RI, Masellis M. Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology. 81: 1181. PMID 24062343 DOI: 10.1212/WNL.0b013e3182a7a945  0.32
2013 Atkinson L, Gonzalez A, Kashy DA, Santo Basile V, Masellis M, Pereira J, Chisholm V, Levitan R. Maternal sensitivity and infant and mother adrenocortical function across challenges. Psychoneuroendocrinology. 38: 2943-51. PMID 24007973 DOI: 10.1016/j.psyneuen.2013.08.001  0.52
2013 Day GS, Farb NA, Tang-Wai DF, Masellis M, Black SE, Freedman M, Pollock BG, Chow TW. Salience network resting-state activity: prediction of frontotemporal dementia progression. Jama Neurology. 70: 1249-53. PMID 23959214 DOI: 10.1001/jamaneurol.2013.3258  0.52
2013 Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, ... ... Masellis M, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. Jama Neurology. 70: 727-35. PMID 23588557 DOI: 10.1001/jamaneurol.2013.1925  0.52
2013 Ozdemir V, Borda-Rodriguez A, Dove ES, Ferguson LR, Huzair F, Manolopoulos VG, Masellis M, Milius D, Warnich L, Srivastava S. Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation. Current Pharmacogenomics and Personalized Medicine. 11: 1-4. PMID 23531886 DOI: 10.2174/1875692111311010001  0.52
2013 Lam B, Masellis M, Freedman M, Stuss DT, Black SE. Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome. Alzheimer's Research & Therapy. 5: 1. PMID 23302773 DOI: 10.1186/alzrt155  0.52
2013 Farb NA, Grady CL, Strother S, Tang-Wai DF, Masellis M, Black S, Freedman M, Pollock BG, Campbell KL, Hasher L, Chow TW. Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 49: 1856-73. PMID 23092697 DOI: 10.1016/j.cortex.2012.09.008  0.52
2013 Schwindt GC, Chaudhary S, Crane D, Ganda A, Masellis M, Grady CL, Stefanovic B, Black SE. Modulation of the default-mode network between rest and task in Alzheimer's Disease. Cerebral Cortex (New York, N.Y. : 1991). 23: 1685-94. PMID 22693345 DOI: 10.1093/cercor/bhs160  0.52
2013 Chow TW, Fam D, Graff-Guerrero A, Verhoeff NP, Tang-Wai DF, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG. Fluorodeoxyglucose positron emission tomography in semantic dementia after 6 months of memantine: an open-label pilot study. International Journal of Geriatric Psychiatry. 28: 319-25. PMID 22674572 DOI: 10.1002/gps.3832  0.52
2013 Özdemir V, Llerena A, McKinnon RA, Srivastava S, Dove ES, Ferguson LR, Masellis M, Nair B, Gurwitz D, Warnich L. CPPM 2013 onward: Building a socio-technical GPS for global personalized medicine - A welcome to editors-in-chief Adrián LLerena (Spain) and Ross A. McKinnon (Australia) Current Pharmacogenomics and Personalized Medicine. 11: 87-92. DOI: 10.2174/1875692111311020001  0.52
2012 Xi Z, Zinman L, Grinberg Y, Moreno D, Sato C, Bilbao JM, Ghani M, Hernández I, Ruiz A, Boada M, Morón FJ, Lang AE, Marras C, Bruni A, Colao R, ... ... Masellis M, et al. Investigation of c9orf72 in 4 neurodegenerative disorders. Archives of Neurology. 69: 1583-90. PMID 22964832 DOI: 10.1001/archneurol.2012.2016  0.52
2012 Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, Jia J, Gauthier S. Early-onset familial Alzheimer's disease (EOFAD). The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 436-45. PMID 22728850  0.52
2012 Ozdemir V, Fisher E, Dove ES, Burton H, Wright GE, Masellis M, Warnich L. End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine. Current Pharmacogenomics and Personalized Medicine. 10: 1-6. PMID 22545073  0.52
2012 Kalia LV, Mozessohn L, Aviv RI, da Costa L, Lang AE, Shadowitz S, Masellis M. Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology. 78: 838-9. PMID 22411959 DOI: 10.1212/WNL.0b013e318249f733  0.52
2012 Dandara C, Adebamowo C, de Vries J, Dove ES, Fisher E, Gibbs RA, Hotez PJ, Kickbusch I, Knoppers BM, Masellis M, Oestergaard MZ, Pang T, Rotimi CN. An idea whose time has come? An African foresight observatory on genomics medicine and data-intensive global science Current Pharmacogenomics and Personalized Medicine. 10: 7-15.  0.52
2011 Shamy MC, Zai C, Basile VS, Kennedy JL, Müller DJ, Masellis M. Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor. Current Pharmacogenomics and Personalized Medicine. 9: 94-101. PMID 22282718 DOI: 10.2174/187569211795508448  0.52
2011 Chow TW, Graff-Guerrero A, Verhoeff NP, Binns MA, Tang-Wai DF, Freedman M, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG. Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia. Neuropsychiatric Disease and Treatment. 7: 415-24. PMID 21792308 DOI: 10.2147/NDT.S22635  0.52
2011 Magistroni R, Cantù M, Ligabue G, Masellis M, Spisni E, Furci L, Lupo V, Genovese F, Cavazzini F, Albertazzi A. Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers. Journal of Nephrology. 24: 329-37. PMID 20872352 DOI: 10.5301/JN.2010.5707  0.52
2011 Kamal SM, Warnich L, Ferguson LR, Srivastava S, Ray S, Avard D, Joly Y, le Huynh M, Page M, Masellis M, Dove ES, Gurwitz D, Ozdemir V. Forward look: Tenth anniversary of the human genome sequence and 21 st century postgenomics global health - A close up on Africa and women's health Current Pharmacogenomics and Personalized Medicine. 9: 148-155.  0.52
2010 Gabryelewicz T, Masellis M, Berdynski M, Bilbao JM, Rogaeva E, St George-Hyslop P, Barczak A, Czyzewski K, Barcikowska M, Wszolek Z, Black SE, Zekanowski C. Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN). Journal of Alzheimer's Disease : Jad. 22: 1123-33. PMID 20930269 DOI: 10.3233/JAD-2010-101413  0.52
2010 Masellis M, Zinman L, Black SE. More than just 'frontal': disentangling behavioural disturbances in amyotrophic lateral sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 5-7. PMID 19832904 DOI: 10.1111/j.1468-1331.2009.02800.x  0.52
2009 Lam B, Hollingdrake E, Kennedy JL, Black SE, Masellis M. Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story. Human Genomics. 4: 91-106. PMID 20038497 DOI: 10.1186/1479-7364-4-2-91  0.52
2009 Magistroni R, Ligabue G, Lupo V, Furci L, Leonelli M, Manganelli L, Masellis M, Gatti V, Cavazzini F, Tizzanini W, Albertazzi A. Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 24: 1672-81. PMID 19211645 DOI: 10.1093/ndt/gfp020  0.52
2008 Masellis M, Black SE. Assessing patients complaining of memory impairment Geriatrics and Aging. 11: 168-178.  0.52
2007 Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M, Ginovart N, Tharmalingam S, Masellis M, Houle S, Meyer JH. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biological Psychiatry. 62: 327-31. PMID 17210141 DOI: 10.1016/j.biopsych.2006.09.022  0.52
2006 Masellis M, Momeni P, Meschino W, Heffner R, Elder J, Sato C, Liang Y, St George-Hyslop P, Hardy J, Bilbao J, Black S, Rogaeva E. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain : a Journal of Neurology. 129: 3115-23. PMID 17030534 DOI: 10.1093/brain/awl276  0.52
2006 Levitan RD, Masellis M, Lam RW, Kaplan AS, Davis C, Tharmalingam S, Mackenzie B, Basile VS, Kennedy JL. A birth-season/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2498-503. PMID 16760922 DOI: 10.1038/sj.npp.1301121  0.52
2006 Propst EJ, Hales S, Masellis M, Adejumo AO, Godkin MD. The beginning of one's real ethical development. Clinical and Investigative Medicine. MéDecine Clinique Et Experimentale. 29: 7-9. PMID 16553357  0.52
2006 Magistroni R, Furci L, Leonelli M, Masellis M, Ligabue G, Lucchi L, Lupo A, Brezzi B, Gambaro G, Manganelli L, Pedrazzi G, Ricardi M, Bormioli L, Albertazzi A. A validated model of disease progression in IgA nephropathy. Journal of Nephrology. 19: 32-40. PMID 16523423  0.52
2006 Levitan RD, Kaplan AS, Masellis M, Basile VS, Richter MA, Kennedy JL. The serotonin-1Dbeta receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 1-6. PMID 15944142 DOI: 10.1016/j.euroneuro.2005.04.016  0.52
2006 Masellis M, Basile VS, Kennedy JL. Neuropsychopharmacogenetics: 'Stimulating' rationale therapy in attention-deficit/hyperactivity disorder (ADHD): Pharmacogenetics of psychostimulants in ADHD Psychopharmacogenetics. 231-248. DOI: 10.1007/0-387-34577-2_9  0.52
2005 Praschak-Rieder N, Willeit M, Zill P, Winkler D, Thierry N, Konstantinidis A, Masellis M, Basile VS, Bondy B, Ackenheil M, Neumeister A, Kaplan AS, Kennedy JL, Kasper S, Levitan R. A Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative study. Journal of Psychiatric Research. 39: 561-7. PMID 16157158 DOI: 10.1016/j.jpsychires.2005.01.007  0.52
2004 Levitan RD, Masellis M, Basile VS, Lam RW, Kaplan AS, Davis C, Muglia P, Mackenzie B, Tharmalingam S, Kennedy SH, Macciardi F, Kennedy JL. The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biological Psychiatry. 56: 665-9. PMID 15522250 DOI: 10.1016/j.biopsych.2004.08.013  0.52
2004 Ertugrul A, Kennedy JL, Masellis M, Basile VS, Jayathilake K, Meltzer HY. No association of the T102C polymorphism of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia. Schizophrenia Research. 69: 301-5. PMID 15469201 DOI: 10.1016/S0920-9964(03)00126-9  0.52
2004 De Luca V, Muglia P, Masellis M, Jane Dalton E, Wong GW, Kennedy JL. Polymorphisms in glutamate decarboxylase genes: analysis in schizophrenia. Psychiatric Genetics. 14: 39-42. PMID 15091314 DOI: 10.1097/00041444-200403000-00006  0.52
2004 Levitan RD, Masellis M, Lam RW, Muglia P, Basile VS, Jain U, Kaplan AS, Tharmalingam S, Kennedy SH, Kennedy JL. Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 179-86. PMID 14560322 DOI: 10.1038/sj.npp.1300314  0.52
2003 Goldberg S, Levitan R, Leung E, Masellis M, Basile VS, Nemeroff CB, Atkinson L. Cortisol concentrations in 12- to 18-month-old infants: stability over time, location, and stressor. Biological Psychiatry. 54: 719-26. PMID 14512212 DOI: 10.1016/S0006-3223(03)00010-6  0.52
2003 Johansson C, Willeit M, Levitan R, Partonen T, Smedh C, Del Favero J, Bel Kacem S, Praschak-Rieder N, Neumeister A, Masellis M, Basile V, Zill P, Bondy B, Paunio T, Kasper S, et al. The serotonin transporter promoter repeat length polymorphism, seasonal affective disorder and seasonality. Psychological Medicine. 33: 785-92. PMID 12877393 DOI: 10.1017/S0033291703007372  0.52
2003 Masellis M, Rector NA, Richter MA. Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 72-7. PMID 12655903  0.52
2003 Potkin SG, Basile VS, Jin Y, Masellis M, Badri F, Keator D, Wu JC, Alva G, Carreon DT, Bunney WE, Fallon JH, Kennedy JL. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Molecular Psychiatry. 8: 109-13. PMID 12556915 DOI: 10.1038/sj.mp.4001191  0.52
2002 Basile VS, Masellis M, De Luca V, Meltzer HY, Kennedy JL. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet. 360: 1790-1. PMID 12480467  0.52
2002 Tsai SJ, Hong CJ, Yu YWY, Lin CH, Basile VS, Masellis M, De Luca V, Meltzer HY, Kennedy JL. -759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain [8] (multiple letters) Lancet. 360: 1790-1791. PMID 12480466  0.52
2002 Basile VS, Masellis M, Potkin SG, Kennedy JL. Pharmacogenomics in schizophrenia: the quest for individualized therapy. Human Molecular Genetics. 11: 2517-30. PMID 12351588  0.52
2002 Levitan RD, Masellis M, Basile VS, Lam RW, Jain U, Kaplan AS, Kennedy SH, Siegel G, Walker ML, Vaccarino FJ, Kennedy JL. Polymorphism of the serotonin-2A receptor gene (HTR2A) associated with childhood attention deficit hyperactivity disorder (ADHD) in adult women with seasonal affective disorder. Journal of Affective Disorders. 71: 229-33. PMID 12167522 DOI: 10.1016/S0165-0327(01)00372-X  0.52
2002 Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, Aschauer HN, McCreadie RG, Ohlraun S, Ferrier N, Masellis M, Verga M, Scharfetter J, Rietschel M, Lovlie R, et al. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 105-19. PMID 12062911 DOI: 10.1016/S0893-133X(02)00293-2  0.52
2002 Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. The Journal of Clinical Psychiatry. 63: 181-6. PMID 11926715  0.52
2002 Masellis M, Basile VS, Muglia P, Ozdemir V, Macciardi FM, Kennedy JL. Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder. Behavioural Brain Research. 130: 85-90. PMID 11864722 DOI: 10.1016/S0166-4328(01)00436-3  0.52
2001 Levitan RD, Kaplan AS, Masellis M, Basile VS, Walker ML, Lipson N, Siegel GI, Woodside DB, Macciardi FM, Kennedy SH, Kennedy JL. Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biological Psychiatry. 50: 640-3. PMID 11690602 DOI: 10.1016/S0006-3223(01)01201-X  0.52
2001 Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. The Journal of Clinical Psychiatry. 62: 45-66. PMID 11603885  0.52
2001 Basile VS, Ozdemir V, Masellis M, Meltzer HY, Lieberman JA, Potkin SG, Macciardi FM, Petronis A, Kennedy JL. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia. Molecular Psychiatry. 6: 230-4. PMID 11317228 DOI: 10.1038/sj.mp.4000847  0.52
2001 Ozdemir V, Basile VS, Masellis M, Kennedy JL. Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes. Journal of Biochemical and Biophysical Methods. 47: 151-7. PMID 11179771 DOI: 10.1016/S0165-022X(00)00161-5  0.52
2001 Masellis M, Basile VS, Meltzer HY, Lieberman JA, Sevy S, Goldman DA, Hamblin MW, Macciardi FM, Kennedy JL. Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophrenia Research. 47: 49-58. PMID 11163544 DOI: 10.1016/S0920-9964(00)00016-5  0.52
2001 Masellis M, Basile VS, DeLuca V, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. Alpha-1A adrenergic (ADRA1A) and serotonin 6 (HTR6) receptor gene polymorphisms and clinical response to clozapine American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 642.  0.52
2001 Basile VS, Masellis M, DeLuca V, Meltzer HY, Lieberman JA, Kennedy JL. Pharmacogenetic dissection of central and peripheral candidate genes in atypical antipsychotic-induced weight-gain American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 581-582.  0.52
2000 Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA, Potkin SG, Alva G, Kalow W, Macciardi FM, Kennedy JL. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia. Molecular Psychiatry. 5: 410-7. PMID 10889552  0.52
2000 Masellis M, Basile VS, Ozdemir V, Meltzer HY, Macciardi FM, Kennedy JL. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine. Biological Psychiatry. 47: 252-66. PMID 10682223 DOI: 10.1016/S0006-3223(99)00298-X  0.52
2000 Basile VS, Masellis M, Ozdemir V, Walker ML, Meltzer HY, Lieberman JA, Potkin SG, Alva G, Kennedy JL. Pharmacogenetics of antipsychotic induced weight gain and tardive dyskinesia American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 467.  0.52
2000 Basile VS, Masellis M, Ozdemir V, Quiterio S, Meltzer HY, Lieberman JA, Mancama D, Arranz MJ, Kerwin RW, Kennedy JL. Novel histamine H1 gene polymorphism and clozapine-induced weight gain American Journal of Medical Genetics - Neuropsychiatric Genetics. 96: 538-539.  0.52
1999 Basile VS, Masellis M, Badri F, Paterson AD, Meltzer HY, Lieberman JA, Potkin SG, Macciardi F, Kennedy JL. Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 17-27. PMID 10379516 DOI: 10.1016/S0893-133X(98)00114-6  0.52
1999 Rietschel M, Kennedy JL, Macciardi F, Meltzer HY. Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies. Schizophrenia Research. 37: 191-6. PMID 10374654 DOI: 10.1016/S0920-9964(98)00153-4  0.52
1999 Vincent JB, Masellis M, Lawrence J, Choi V, Gurling HM, Parikh SV, Kennedy JL. Genetic association analysis of serotonin system genes in bipolar affective disorder. The American Journal of Psychiatry. 156: 136-8. PMID 9892311  0.52
1999 Ozdemir V, Masellis M, Basile VS, Kalow W, Meltzer HY, Lieberman JA, Kennedy JL. Variability in response to clozapine: Potential role of cytochrome P450 1A2 and the dopamine D4 receptor gene Cns Spectrums. 4: 30-56.  0.52
1998 Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, Cola P, Howard A, Badri F, Nöthen MM, Kalow W, Kennedy JL. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 19: 123-32. PMID 9629566 DOI: 10.1016/S0893-133X(98)00007-4  0.52
1998 Potkin SG, Kennedy J, Badri F, Jin Y, Masellis M, Keator DB, Frost J, Wu JC, Najafi A. A genetic PET scan study: D1 alleles predict clinical response to clozapine and corresponding brain metabolism American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 496-497.  0.52
1997 Manassis K, Tannock R, Mendlowitz S, Laslo D, Masellis M. Distinguishing anxiety disorders psychometrically. Journal of the American Academy of Child and Adolescent Psychiatry. 36: 1645-6. PMID 9401317 DOI: 10.1097/00004583-199712000-00001  0.52
1997 King N, Bassett AS, Honer WG, Masellis M, Kennedy JL. Absence of linkage for schizophrenia on the short arm of chromosome 5 in multiplex Canadian families. American Journal of Medical Genetics. 74: 472-4. PMID 9342193 DOI: 10.1002/(SICI)1096-8628(19970919)74:5<472::AID-AJMG2>3.0.CO;2-Q  0.52
1996 Manassis K, Tannock R, Masellis M. Cognitive differences between anxious, normal, and ADHD children on a dichotic listening task. Anxiety. 2: 279-85. PMID 9160635  0.52
1995 Masellis M, Paterson AD, Badri F, Lieberman JA, Meltzer HY, Cavazzoni P, Kennedy JL. Genetic variation of 5-HT2A receptor and response to clozapine. Lancet (London, England). 346: 1108. PMID 7564821 DOI: 10.1016/S0140-6736(95)91785-3  0.52
Show low-probability matches.